Global Iliac Stent Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

List of Tables

The global demand for Iliac Stent Market is presumed to reach the market size of nearly USD 2.77 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 6.29% under the study period 2024 - 2032.

An Iliac stent is a small, mesh-like tube inserted into the iliac arteries to treat conditions like peripheral artery disease (PAD). These stents help restore blood flow by providing structural support to the arteries, preventing blockages, and improving circulation in the pelvic region. Placement of this stent is a common medical intervention to alleviate symptoms such as leg pain and cramping associated with reduced blood flow.

MARKET DYNAMIC

The Iliac stent market is primarily driven by the escalating prevalence of peripheral artery disease (PAD), particularly among the aging population, commonly used to treat iliac artery stenosis or occlusion. Furthermore, ongoing technological advancements in stent design, materials, and delivery systems contribute to improved efficacy and safety, attracting healthcare providers and patients. The growing aging demographic globally also enhances the demand for Iliac stents, given the higher incidence of vascular diseases in older individuals. Furthermore, the preference for minimally invasive procedures, such as endovascular interventions like Iliac stenting, is on the rise due to reduced recovery times and lower morbidity rates compared to traditional open surgical options. Lastly, improved awareness of peripheral vascular diseases and advancements in diagnostic techniques contribute to early detection and treatment, further driving the market. However, the high cost associated with Iliac stent procedures and devices may hamper the market growth. This economic barrier may limit adoption, particularly in regions with financial constraints or inadequate healthcare infrastructure, thus impacting the market's growth potential.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of iliac stent. The growth and trends of iliac stent industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the iliac stent market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Self-Expandable Stents
Balloon-Expandable Stents
Others

By Artery Lesions

Common Iliac Artery Lesions
Severe Calcified Lesions
Complete Obstructive Lesions

By End-Use

Hospitals
Outpatient Facilities
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Iliac Stent market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL ILIAC STENT MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Iliac Stent Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Iliac Stent market include BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Cook, Medtronic, iVascular, Terumo Corporation, Biotronik SE & Co KG, Getinge AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113948

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ILIAC STENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Artery Lesions
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ILIAC STENT MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Self-Expandable Stents Historic and Forecast Sales by Regions
5.5 Balloon-Expandable Stents Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ILIAC STENT MARKET ANALYSIS BY ARTERY LESIONS

6.1 Overview by Artery Lesions
6.2 Historical and Forecast Data
6.3 Analysis by Artery Lesions
6.4 Common Iliac Artery Lesions Historic and Forecast Sales by Regions
6.5 Severe Calcified Lesions Historic and Forecast Sales by Regions
6.6 Complete Obstructive Lesions Historic and Forecast Sales by Regions

7 . GLOBAL ILIAC STENT MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Outpatient Facilities Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ILIAC STENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ILIAC STENT COMPANIES

9.1. Iliac Stent Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF ILIAC STENT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BD
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbott
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Boston Scientific Corporation
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. W. L. Gore & Associates Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Cook
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Medtronic
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. iVascular
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Terumo Corporation
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Biotronik SE & Co KG
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Getinge AB.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies